About
Refoxy Pharmaceuticals develops innovative medicines targeting the FOXO3 transcription factor to treat age-related diseases such as Idiopathic Pulmonary Fibrosis by enhancing cellular resilience and extending healthy lifespan.
Explore Refoxy Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.